company background image
5OT

Singapore Medical Group Catalist:5OT Stock Report

Last Price

S$0.31

Market Cap

S$150.8m

7D

0%

1Y

0%

Updated

16 May, 2022

Data

Company Financials +
5OT fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends2/6

5OT Stock Overview

Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore.

Singapore Medical Group Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Singapore Medical Group
Historical stock prices
Current Share PriceS$0.31
52 Week HighS$0.35
52 Week LowS$0.28
Beta0.84
1 Month Change-4.61%
3 Month Change1.64%
1 Year Change0%
3 Year Change-25.30%
5 Year Change-46.09%
Change since IPO29.17%

Recent News & Updates

Shareholder Returns

5OTSG HealthcareSG Market
7D0%-0.8%-2.4%
1Y0%-4.1%-1.1%

Return vs Industry: 5OT matched the SG Healthcare industry which returned -0.1% over the past year.

Return vs Market: 5OT matched the SG Market which returned -0.1% over the past year.

Price Volatility

Is 5OT's price volatile compared to industry and market?
5OT volatility
5OT Average Weekly Movement4.3%
Healthcare Industry Average Movement6.5%
Market Average Movement5.2%
10% most volatile stocks in SG Market12.1%
10% least volatile stocks in SG Market2.4%

Stable Share Price: 5OT is not significantly more volatile than the rest of SG stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 5OT's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005303Meng Deliang Benghttps://www.smg.sg

Singapore Medical Group Limited operates medical clinics and provides general medical services in Singapore. The company operates through three segments: Health Business, Diagnostic & Aesthetics Business, and Others. The Health Business segment offers obstetrical and gynaecological services for the wellness of women; oncology services, including the prevention, diagnosis, and treatment of cancer, cancer screening and cancer genetic, and risk assessment; endocrinology services; general medicine and health screening services; cardiology services; and paediatrics services.

Singapore Medical Group Fundamentals Summary

How do Singapore Medical Group's earnings and revenue compare to its market cap?
5OT fundamental statistics
Market CapS$150.78m
Earnings (TTM)S$15.61m
Revenue (TTM)S$100.84m

9.7x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
5OT income statement (TTM)
RevenueS$100.84m
Cost of RevenueS$56.65m
Gross ProfitS$44.19m
Other ExpensesS$28.58m
EarningsS$15.61m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.032
Gross Margin43.82%
Net Profit Margin15.48%
Debt/Equity Ratio2.2%

How did 5OT perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

20%

Payout Ratio

Valuation

Is Singapore Medical Group undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 5OT (SGD0.31) is trading below our estimate of fair value (SGD1.11)

Significantly Below Fair Value: 5OT is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 5OT is good value based on its PE Ratio (9.7x) compared to the SG Healthcare industry average (15.8x).

PE vs Market: 5OT is good value based on its PE Ratio (9.7x) compared to the SG market (11.6x).


Price to Earnings Growth Ratio

PEG Ratio: 5OT is poor value based on its PEG Ratio (1.2x)


Price to Book Ratio

PB vs Industry: 5OT is good value based on its PB Ratio (0.9x) compared to the SG Healthcare industry average (1.7x).


Future Growth

How is Singapore Medical Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


7.8%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 5OT's forecast earnings growth (7.8% per year) is above the savings rate (1.8%).

Earnings vs Market: 5OT's earnings (7.8% per year) are forecast to grow slower than the SG market (11.8% per year).

High Growth Earnings: 5OT's earnings are forecast to grow, but not significantly.

Revenue vs Market: 5OT's revenue (5.8% per year) is forecast to grow slower than the SG market (7.5% per year).

High Growth Revenue: 5OT's revenue (5.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 5OT's Return on Equity is forecast to be low in 3 years time (9.9%).


Past Performance

How has Singapore Medical Group performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


14.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 5OT has high quality earnings.

Growing Profit Margin: 5OT's current net profit margins (15.5%) are higher than last year (10%).


Past Earnings Growth Analysis

Earnings Trend: 5OT's earnings have grown by 14.8% per year over the past 5 years.

Accelerating Growth: 5OT's earnings growth over the past year (78.8%) exceeds its 5-year average (14.8% per year).

Earnings vs Industry: 5OT earnings growth over the past year (78.8%) exceeded the Healthcare industry 44%.


Return on Equity

High ROE: 5OT's Return on Equity (9.4%) is considered low.


Financial Health

How is Singapore Medical Group's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 5OT's short term assets (SGD36.0M) exceed its short term liabilities (SGD26.5M).

Long Term Liabilities: 5OT's short term assets (SGD36.0M) exceed its long term liabilities (SGD8.8M).


Debt to Equity History and Analysis

Debt Level: 5OT has more cash than its total debt.

Reducing Debt: 5OT's debt to equity ratio has reduced from 4.9% to 2.2% over the past 5 years.

Debt Coverage: 5OT's debt is well covered by operating cash flow (664.5%).

Interest Coverage: 5OT's interest payments on its debt are well covered by EBIT (34.6x coverage).


Balance Sheet


Dividend

What is Singapore Medical Group current dividend yield, its reliability and sustainability?

Dividend Score

1/6

Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.10%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 5OT's dividend (2.1%) isn’t notable compared to the bottom 25% of dividend payers in the SG market (2.22%).

High Dividend: 5OT's dividend (2.1%) is low compared to the top 25% of dividend payers in the SG market (5.91%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, 5OT has been paying a dividend for less than 10 years.

Growing Dividend: 5OT's dividend payments have increased, but the company has only paid a dividend for 2 years.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (20.1%), 5OT's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (15.6%), 5OT's dividend payments are well covered by cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.4yrs

Average management tenure


CEO

Meng Deliang Beng (50 yo)

8.42yrs

Tenure

Dr. Teck Liang Beng, also known as Meng Deliang, has been the Chief Executive Officer at Singapore Medical Group Limited since December 2, 2013 and serves as its Executive Director. Dr. Beng served as Gene...


Leadership Team

Experienced Management: 5OT's management team is seasoned and experienced (8.4 years average tenure).


Board Members

Experienced Board: 5OT's board of directors are considered experienced (8.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Singapore Medical Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Singapore Medical Group Limited
  • Ticker: 5OT
  • Exchange: Catalist
  • Founded: 2005
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: S$150.778m
  • Shares outstanding: 486.38m
  • Website: https://www.smg.sg

Number of Employees


Location

  • Singapore Medical Group Limited
  • 1004 Toa Payoh North
  • No. 06-03 to 07
  • Singapore
  • 318995
  • Singapore

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/16 00:00
End of Day Share Price2022/05/14 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.